Table 4.
Clinical and epidemiological profiles of autoimmunized and non-autoimmunized multi-transfused patients.
| Autoimmunized (n = 10) | Non-autoimmunized (n = 143) | p-value | |
|---|---|---|---|
| Gender – n (%) | |||
| Female | 8 (10.12) | 71 (89.88) | 0.1262 |
| Male | 2 (2.70) | 72 (97.30) | |
| Age group – n (%) | |||
| <30 | 4 (4.54) | 84 (95.48) | 0.4044 |
| 30–50 | 2 (6.89) | 27 (93.11) | |
| >50 | 4 (11.11) | 32 (88.89) | |
| Diagnosis – n (%) | |||
| Hemoglobinopathies | 4 (6.25) | 60 (93.75) | 0.0329 |
| Onco-hematological diseases | 2 (2.94) | 66 (97.06) | |
| Chronic renal failure | 4 (19.04) | 17 (80.96) | |
| Transfusions – n (%) | |||
| <6 | 2 (5.26) | 36 (94.74) | 0.0203 |
| 6–10 | 6 (16.21) | 31 (83.79) | |
| >10 | 2 (2.56) | 76 (97.44) | |